Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial
EndocrinologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Diabetes, obesity & metabolism
- Publicado em
- 3 nov 2023
- Citações
- 35
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial
Yves Reznik, Martin Carvalho, Salha Fendri, Gaetan Prevost, Lucy Chaillous, Jean-Pierre Riveline, Hélène Hanaire, Séverine Dubois, Patrick Houéto, Hélène Pasche et al.
Descritores MeSH
- Hypoglycemia
- Diabetes Mellitus, Type 1
- Home Care Services
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents
- Insulin
- Insulin Infusion Systems
- Quality of Life
- Blood Glucose Self-Monitoring
- Treatment Outcome
Veja também
Estudos relacionados
- A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72
- Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials
- Clinical evidence for high-risk CE-marked medical devices for glucose management: A systematic review and meta-analysis
- Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial